BioScrip to Present at Bank of America Merrill Lynch Leveraged Finance Conference

BioScrip (NASDAQ: BIOS) today announced that the Company will present at the Bank of America Merrill Lynch Leveraged Finance Conference to be held Wednesday, November 30 - Friday, December 2, 2011 at the Loews Royal Pacific Resort at Universal Orlando® in Orlando, Florida.

Richard M. Smith, President and Chief Executive Officer, and MJ Graves, interim Chief Financial Officer and Treasurer, will present on Wednesday, November 30, 2011 at 4 p.m. Eastern Standard Time. The presentation will also be available via a live audio webcast at the following link: https://www.veracast.com/webcasts/baml/credit2011/id17550800.cfm

Following each presentation, a replay will be available through BioScrip's website at www.bioscrip.com under the "Investors" section and will remain available for two weeks after the actual presentation date.

About BioScrip

BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a national provider of specialty pharmacy and home health services that partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and delivery of cost-effective access to prescription medications and home health services. Our services are designed to improve clinical outcomes with chronic and acute healthcare conditions while controlling overall healthcare costs.

BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024